A pragmatic randomised controlled trial to evaluate physical activity as a treatment for depression

ISRCTN ISRCTN16900744
DOI https://doi.org/10.1186/ISRCTN16900744
Secondary identifying numbers HTA 03/45/07
Submission date
15/02/2007
Registration date
16/02/2007
Last edited
07/06/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
There is some evidence that exercise can improve outcome in depression but the current evidence is rather limited and the studies have been too small to provide accurate estimates of any possible benefit. Exercise on prescription is used to describe arrangements whereby a doctor will recommend to a patient that they carry out a systematic programme of exercise. They have mostly been provided for people with cardiovascular (heart) disease. The aim of this study is to investigate whether exercise on prescription affects outcome in depression when used in addition to the usual care of depression that is usually treated with antidepressants.

Who can participate?
Patients aged 18-69 with mild/moderate depression

What does the study involve?
Participants are randomly allocated to one of two groups. One group receives exercise on prescription in addition to usual care. The other group receives usual care. We measure depression over 24 months and also measure antidepressant use, quality of life and costs.

What are the possible benefits and risks of participating?
Not provided at time of registration

Where is the study run from?
University of Bristol (UK)

When is the study starting and how long is it expected to run for?
August 2006 to January 2011

Who is funding the study?
Health Technology Assessment Programme (UK)

Who is the main contact?
Prof. Glyn Lewis
glyn.lewis@bristol.ac.uk

Contact information

Prof Glyn Lewis
Scientific

Academic Unit of Psychiatry
School of Social and Community Medicine
University of Bristol
Oakfield House
Oakfield Grove
Bristol
BS8 2BN
United Kingdom

Phone +44 (0)117 331 4027
Email glyn.lewis@bristol.ac.uk

Study information

Study designTwo-arm multi-centre pragmatic randomised controlled trial with randomisation at the level of the individual participant
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)GP practice
Study typeTreatment
Participant information sheet Not available in web format, please use contact details to request a participant information sheet
Scientific titleA pragmatic randomised controlled TRial to Evaluate physical Activity as a treatment for Depression
Study acronymTREAD
Study objectivesCurrent study hypothesis as of 10/04/2012
Does facilitated physical activity, in addition to usual care in primary health care, change the outcome in depression and alter the subsequent use of antidepressant medication?

Previous study hypothesis
Does physical activity, in addition to usual care in primary health care, change the outcome in depression and alter the subsequent use of antidepressant medication?

More details can be found at: http://www.nets.nihr.ac.uk/projects/hta/034507
Protocol can be found at: http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0013/51007/PRO-03-45-07.pdf
Ethics approval(s)West Midlands Multi-centre Research Ethics Committee, 20/10/2005, ref: 05/MRE07/42
Health condition(s) or problem(s) studiedMild/moderate depression
InterventionCurrent interventions as of 10/04/2012
The TREAD intervention aims to increase self-esteem, confidence and social interaction as well as the take-up of physical activity, through the use of motivational techniques and drawing upon the theories of social cognition and self-determination. It comprises a series of face-to-face meetings and telephone contacts, negotiated between participants and a designated Physical Activity Facilitator (PAF) over a 8-month period.

Previous interventions
The TREAD intervention aims to increase self-esteem, confidence and social interaction as well as the take-up of physical activity, through the use of motivational techniques and drawing upon the theories of social cognition and self-determination. It comprises a series of face-to-face meetings and telephone contacts, negotiated between participants and a designated Physical Activity Facilitator (PAF) over a 12-month period.
Intervention typeBehavioural
Primary outcome measureCurrent primary outcome measures as of 10/04/2012:
Change in clinical symptoms of depression assessed using Beck Depression Inventory at 4-months post-randomisation.

Previous primary outcome measures:
Change in clinical symptoms of depression assessed using Beck Depression Inventory at 3-months post-randomisation.
Secondary outcome measuresCurrent secondary outcome measures as of 10/04/2012:
A number of secondary outcomes will be measured at various points throughout the trial (4-months, 8-months, 12-months post-randomisation) including change in use of anti-depressants, uptake of physical activity, exercise efficacy and quality of life .

Previous secondary outcome measures:
A number of secondary outcomes will be measured at various points throughout the trial (3-months, 12-months, 24-months post-randomisation) including change in use of anti-depressants, uptake of physical activity, physical self-perceptions, exercise efficacy, psychiatric co-morbidity, quality of life and social support.
Overall study start date01/08/2006
Completion date31/01/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit69 Years
SexBoth
Target number of participants361
Key inclusion criteriaPatients aged 18-69 diagnosed by GPs as having a new episode of mild/moderate depression (ICD-10 diagnosis and a score of 14 or more on Beck Depression Inventory)
Key exclusion criteria1. Physical contraindications to exercise
2. Inability to complete self-administered questionnaires
3. Psychosis
4. Serious drug or alcohol abuse
5. Pregnancy at time of randomisation
Date of first enrolment01/08/2006
Date of final enrolment31/01/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Bristol
Bristol
BS8 2BN
United Kingdom

Sponsor information

University of Bristol (UK)
University/education

Research, Enterprise and Development office
University of Bristol
Senate House
Tyndall Avenue
Bristol
BS8 1TH
England
United Kingdom

Phone +44 (0)117 928 9000
Email vince.boyle@bristol.ac.uk
ROR logo "ROR" https://ror.org/0524sp257

Funders

Funder type

Government

Health Technology Assessment Programme
Government organisation / National government
Alternative name(s)
NIHR Health Technology Assessment Programme, HTA
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 12/11/2010 Yes No
Other publications rationale and development 01/12/2010 Yes No
Results article results 01/04/2011 Yes No
Results article cost-effectiveness results 01/06/2012 Yes No
Results article results 06/06/2012 Yes No

Editorial Notes

07/06/2016: Plain English summary added.

10/04/2012: the target number of participants was changed from 762 to 361 in order to reflect our revised recruitment target approved under version 5 of the study protocol